Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 30:8:667776.
doi: 10.3389/fmed.2021.667776. eCollection 2021.

Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study

Yue Zheng  1   2   3   4 , Nana Xu  5 , Jiaojiao Pang  1   2   3   4 , Hui Han  6 , Hongna Yang  6 , Weidong Qin  6 , Hui Zhang  6 , Wei Li  7 , Hao Wang  1   6   8 , Yuguo Chen  1   2   3   4
Affiliations

Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study

Yue Zheng et al. Front Med (Lausanne). .

Abstract

Background: Acinetobacter baumannii is one of the most frequently isolated opportunistic pathogens in intensive care units (ICUs). Extensively drug-resistant A. baumannii (XDR-AB) strains lack susceptibility to almost all antibiotics and pose a heavy burden on healthcare institutions. In this study, we evaluated the impact of XDR-AB colonization on both the short-term and long-term survival of critically ill patients. Methods: We prospectively enrolled patients from two adult ICUs in Qilu Hospital of Shandong University from March 2018 through December 2018. Using nasopharyngeal and perirectal swabs, we evaluated the presence of XDR-AB colonization. Participants were followed up for 6 months. The primary endpoints were 28-day and 6-month mortality after ICU admission. The overall survival rate was estimated by the Kaplan-Meier method. We identified risk factors associated with 28-day and 6-month mortality using the logistic regression model and a time-dependent Cox regression model, respectively. Results: Out of 431 patients, 77 were colonized with XDR-AB. Based on the Kaplan-Meier curve results, the overall survival before 28 days did not differ by colonization status; however, a significantly lower overall survival rate was obtained at 6 months in colonized patients. Univariate and multivariate analysis results confirmed that XDR-AB colonization was not associated with 28-day mortality, but was an independent risk factor of lower overall survival at 6 months (HR = 1.749, 95% CI = 1.174-2.608). Conclusions: XDR-AB colonization has no effect on short-term overall survival, but is associated with lower long-term overall survival in critically ill patients.

Keywords: Acinetobacter baumannii; colonization; extensively drug resistant; infection; intensive care unit.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Kaplan-Meier survival analysis stratified by XDR-AB colonization and no colonization. Survival of patients was followed for 6 months. (A) Kaplan-Meier analysis of survival in colonized and non-colonized patients. (B) Survival curves before and after 28 days. (C,D) Landmark analysis discriminating between events occurring before and after 28 days of follow-up.
Figure 2
Figure 2
Subgroups analyses of the impact of XDR-AB colonization on mortality at 6 months. Shown are hazard ratios for 6-month survival with XDR-AB colonization compared with no colonization. *Included burns and hepatobiliary, pancreatic, gastrointestinal, and genitourinary diseases.
See this image and copyright information in PMC

References

    1. Falagas ME, Karveli EA, Siempos II, Vardakas KZ. Acinetobacter infections: a growing threat for critically ill patients. Epidemiol Infect. (2008) 136:1009–19. 10.1017/S0950268807009478 - DOI - PMC - PubMed
    1. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. (2007) 51:3471–84. 10.1128/AAC.01464-06 - DOI - PMC - PubMed
    1. Chinese XDRCWG, Guan X, He L, Hu B, Hu J, Huang X, et al. . Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect. (2016) 22(Suppl. 1):S15–25. 10.1016/j.cmi.2015.11.004 - DOI - PubMed
    1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. (2007) 5:939–51. 10.1038/nrmicro1789 - DOI - PubMed
    1. Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, et al. . Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med. (2015) 41:2057–75. 10.1007/s00134-015-4079-4 - DOI - PubMed

LinkOut - more resources